Global Pharmacy Benefit Management (PBM) 麻豆原创 Research Report 2025

Publication ID:

PB503250037

Publication Date:

March 25, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Pharmacy Benefit Management (PBM) was valued at US$ 515320 million in the year 2024 and is projected to reach a revised size of US$ 755530 million by 2031, growing at a CAGR of 5.7% during the forecast period.
The term pharmacy benefit management (PBM) industry refers to a group of companies that serve as the middlemen between insurance companies, pharmacies, and drug manufacturers. PBMs are responsible for securing lower drug costs for insurers and insurance companies. They accomplish this by negotiating with pharmacies and drug manufacturers. The discounts are then passed onto insurance companies. Profits are generated through the slight up-charging of drugs or retaining portions of rebates.
麻豆原创 Driver:
The Pharmacy Benefit Management (PBM) market is driven by the rising demand for cost-effective prescription drug management amid increasing healthcare expenditures. As drug prices continue to rise, PBMs play a crucial role in negotiating discounts, managing formularies, and implementing cost-containment strategies to make medications more affordable for insurers, employers, and patients. The growing prevalence of chronic diseases such as diabetes and cardiovascular disorders has also increased prescription drug usage, further boosting the need for PBM services. Additionally, advancements in digital health technologies, including electronic prior authorization and AI-driven drug utilization review, are enhancing PBM efficiency and expanding market opportunities.
麻豆原创 Challenge:
Despite its benefits, the PBM market faces challenges related to pricing transparency and regulatory scrutiny. Many stakeholders, including policymakers and consumers, criticize PBMs for a lack of transparency in drug pricing and rebate structures, leading to concerns about whether cost savings are fully passed on to patients. Regulatory pressures are also increasing, with governments implementing reforms to ensure fair pricing practices and limit excessive profit margins. Additionally, growing competition from integrated healthcare models鈥攚here insurers and pharmacies establish their own PBM services鈥攑oses a threat to traditional PBM companies, potentially reshaping market dynamics.
Top major PBMs maufacturters include Express Scripts, CVS Health, and OptumRx, which comprise 75% of the market. America is enjoying the largest market share of pharmacy benefit management (PBM), with a market share nearly 97%. EU is the second place, enjoying market share nearly 2%.In terms of product, government is the largest segment, with a share over 70%. And in terms of application, the largest application is non-mail pharmacy services, followed by mail-order pharmacy services.
This report aims to provide a comprehensive presentation of the global market for Pharmacy Benefit Management (PBM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacy Benefit Management (PBM).
The Pharmacy Benefit Management (PBM) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacy Benefit Management (PBM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacy Benefit Management (PBM) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet
CRHMS
Segment by Type
Government
Non-Government
Segment by Application
Mail-order Pharmacy Services
Non-mail Pharmacy Services
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacy Benefit Management (PBM) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Pharmacy Benefit Management (PBM) 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Government
1.2.3 Non-Government
1.3 麻豆原创 by Application
1.3.1 Global Pharmacy Benefit Management (PBM) 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Mail-order Pharmacy Services
1.3.3 Non-mail Pharmacy Services
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacy Benefit Management (PBM) 麻豆原创 Perspective (2020-2031)
2.2 Global Pharmacy Benefit Management (PBM) Growth Trends by Region
2.2.1 Global Pharmacy Benefit Management (PBM) 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacy Benefit Management (PBM) Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Pharmacy Benefit Management (PBM) Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Pharmacy Benefit Management (PBM) 麻豆原创 Dynamics
2.3.1 Pharmacy Benefit Management (PBM) Industry Trends
2.3.2 Pharmacy Benefit Management (PBM) 麻豆原创 Drivers
2.3.3 Pharmacy Benefit Management (PBM) 麻豆原创 Challenges
2.3.4 Pharmacy Benefit Management (PBM) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacy Benefit Management (PBM) Players by Revenue
3.1.1 Global Top Pharmacy Benefit Management (PBM) Players by Revenue (2020-2025)
3.1.2 Global Pharmacy Benefit Management (PBM) Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Pharmacy Benefit Management (PBM) Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacy Benefit Management (PBM) Revenue
3.4 Global Pharmacy Benefit Management (PBM) 麻豆原创 Concentration Ratio
3.4.1 Global Pharmacy Benefit Management (PBM) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacy Benefit Management (PBM) Revenue in 2024
3.5 Global Key Players of Pharmacy Benefit Management (PBM) Head office and Area Served
3.6 Global Key Players of Pharmacy Benefit Management (PBM), Product and Application
3.7 Global Key Players of Pharmacy Benefit Management (PBM), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacy Benefit Management (PBM) Breakdown Data by Type
4.1 Global Pharmacy Benefit Management (PBM) Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Pharmacy Benefit Management (PBM) Forecasted 麻豆原创 Size by Type (2026-2031)
5 Pharmacy Benefit Management (PBM) Breakdown Data by Application
5.1 Global Pharmacy Benefit Management (PBM) Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Pharmacy Benefit Management (PBM) Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Pharmacy Benefit Management (PBM) 麻豆原创 Size (2020-2031)
6.2 North America Pharmacy Benefit Management (PBM) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2020-2025)
6.4 North America Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacy Benefit Management (PBM) 麻豆原创 Size (2020-2031)
7.2 Europe Pharmacy Benefit Management (PBM) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2020-2025)
7.4 Europe Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacy Benefit Management (PBM) 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Pharmacy Benefit Management (PBM) 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacy Benefit Management (PBM) 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacy Benefit Management (PBM) 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacy Benefit Management (PBM) 麻豆原创 Size (2020-2031)
9.2 Latin America Pharmacy Benefit Management (PBM) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacy Benefit Management (PBM) 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Pharmacy Benefit Management (PBM) 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacy Benefit Management (PBM) 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CVS Health (CVS)
11.1.1 CVS Health (CVS) Company Details
11.1.2 CVS Health (CVS) Business Overview
11.1.3 CVS Health (CVS) Pharmacy Benefit Management (PBM) Introduction
11.1.4 CVS Health (CVS) Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.1.5 CVS Health (CVS) Recent Development
11.2 Express Scripts
11.2.1 Express Scripts Company Details
11.2.2 Express Scripts Business Overview
11.2.3 Express Scripts Pharmacy Benefit Management (PBM) Introduction
11.2.4 Express Scripts Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.2.5 Express Scripts Recent Development
11.3 OptumRx (UnitedHealth)
11.3.1 OptumRx (UnitedHealth) Company Details
11.3.2 OptumRx (UnitedHealth) Business Overview
11.3.3 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Introduction
11.3.4 OptumRx (UnitedHealth) Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.3.5 OptumRx (UnitedHealth) Recent Development
11.4 Humana Pharmacy Solutions
11.4.1 Humana Pharmacy Solutions Company Details
11.4.2 Humana Pharmacy Solutions Business Overview
11.4.3 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Introduction
11.4.4 Humana Pharmacy Solutions Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.4.5 Humana Pharmacy Solutions Recent Development
11.5 Prime Therapeutics
11.5.1 Prime Therapeutics Company Details
11.5.2 Prime Therapeutics Business Overview
11.5.3 Prime Therapeutics Pharmacy Benefit Management (PBM) Introduction
11.5.4 Prime Therapeutics Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.5.5 Prime Therapeutics Recent Development
11.6 Medimpact Healthcare
11.6.1 Medimpact Healthcare Company Details
11.6.2 Medimpact Healthcare Business Overview
11.6.3 Medimpact Healthcare Pharmacy Benefit Management (PBM) Introduction
11.6.4 Medimpact Healthcare Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.6.5 Medimpact Healthcare Recent Development
11.7 Magellan Health
11.7.1 Magellan Health Company Details
11.7.2 Magellan Health Business Overview
11.7.3 Magellan Health Pharmacy Benefit Management (PBM) Introduction
11.7.4 Magellan Health Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.7.5 Magellan Health Recent Development
11.8 BC/BS
11.8.1 BC/BS Company Details
11.8.2 BC/BS Business Overview
11.8.3 BC/BS Pharmacy Benefit Management (PBM) Introduction
11.8.4 BC/BS Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.8.5 BC/BS Recent Development
11.9 Vidalink
11.9.1 Vidalink Company Details
11.9.2 Vidalink Business Overview
11.9.3 Vidalink Pharmacy Benefit Management (PBM) Introduction
11.9.4 Vidalink Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.9.5 Vidalink Recent Development
11.10 Sea Rainbow
11.10.1 Sea Rainbow Company Details
11.10.2 Sea Rainbow Business Overview
11.10.3 Sea Rainbow Pharmacy Benefit Management (PBM) Introduction
11.10.4 Sea Rainbow Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.10.5 Sea Rainbow Recent Development
11.11 Cachet
11.11.1 Cachet Company Details
11.11.2 Cachet Business Overview
11.11.3 Cachet Pharmacy Benefit Management (PBM) Introduction
11.11.4 Cachet Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.11.5 Cachet Recent Development
11.12 CRHMS
11.12.1 CRHMS Company Details
11.12.2 CRHMS Business Overview
11.12.3 CRHMS Pharmacy Benefit Management (PBM) Introduction
11.12.4 CRHMS Revenue in Pharmacy Benefit Management (PBM) Business (2020-2025)
11.12.5 CRHMS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet
CRHMS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.